» Articles » PMID: 27352007

Alterations of the Human Gut Microbiome in Multiple Sclerosis

Abstract

The gut microbiome plays an important role in immune function and has been implicated in several autoimmune disorders. Here we use 16S rRNA sequencing to investigate the gut microbiome in subjects with multiple sclerosis (MS, n=60) and healthy controls (n=43). Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas, and correlate with variations in the expression of genes involved in dendritic cell maturation, interferon signalling and NF-kB signalling pathways in circulating T cells and monocytes. Patients on disease-modifying treatment show increased abundances of Prevotella and Sutterella, and decreased Sarcina, compared with untreated patients. MS patients of a second cohort show elevated breath methane compared with controls, consistent with our observation of increased gut Methanobrevibacter in MS in the first cohort. Further study is required to assess whether the observed alterations in the gut microbiome play a role in, or are a consequence of, MS pathogenesis.

Citing Articles

Alzheimer's disease (AD) in multiple sclerosis (MS): A systematic review of published cases, mechanistic links between AD and MS, and possible clinical evaluation of AD in MS.

Cottrill R, Ekanayake A, Grove C, Peiris S, Corbett N, Ahmed B J Alzheimers Dis Rep. 2025; 9:25424823251316134.

PMID: 40034519 PMC: 11864252. DOI: 10.1177/25424823251316134.


How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells.

Schaible P, Henschel J, Erny D J Neuroinflammation. 2025; 22(1):60.

PMID: 40033338 PMC: 11877772. DOI: 10.1186/s12974-025-03371-0.


Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria.

Lu D, Ma X, Tao K, Lei H Curr Issues Mol Biol. 2025; 47(2).

PMID: 39996827 PMC: 11853859. DOI: 10.3390/cimb47020106.


Perturbations in gut microbiota composition in patients with autoimmune neurological diseases: a systematic review and meta-analysis.

Deng X, Gong X, Zhou D, Hong Z Front Immunol. 2025; 16:1513599.

PMID: 39981228 PMC: 11839609. DOI: 10.3389/fimmu.2025.1513599.


Plasma and Visceral Organ Kynurenine Metabolites Correlate in the Multiple Sclerosis Cuprizone Animal Model.

Polyak H, Galla Z, Rajda C, Monostori P, Klivenyi P, Vecsei L Int J Mol Sci. 2025; 26(3).

PMID: 39940744 PMC: 11817772. DOI: 10.3390/ijms26030976.


References
1.
Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh S . Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052):105-8. PMC: 3368382. DOI: 10.1126/science.1208344. View

2.
Furusawa Y, Obata Y, Fukuda S, Endo T, Nakato G, Takahashi D . Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. DOI: 10.1038/nature12721. View

3.
Morgan X, Kabakchiev B, Waldron L, Tyler A, Tickle T, Milgrom R . Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol. 2015; 16:67. PMC: 4414286. DOI: 10.1186/s13059-015-0637-x. View

4.
Tremlett H, Fadrosh D, Faruqi A, Hart J, Roalstad S, Graves J . Gut microbiota composition and relapse risk in pediatric MS: A pilot study. J Neurol Sci. 2016; 363:153-7. PMC: 4806409. DOI: 10.1016/j.jns.2016.02.042. View

5.
Cantarel B, Waubant E, Chehoud C, Kuczynski J, DeSantis T, Warrington J . Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Investig Med. 2015; 63(5):729-34. PMC: 4439263. DOI: 10.1097/JIM.0000000000000192. View